| Name | Title | Contact Details |
|---|---|---|
Richard Silbert |
Vice President, Chief Legal Strategist | Profile |
Karen McCarthy |
Assistant General Counsel, New Ventures | Profile |
Stephanie Franco |
Associate General Counsel | Profile |
Stephanie DiFazio |
Assistant General Counsel, Regulatory | Profile |
Xontogeny is a life sciences accelerator that collaborates with entrepreneurs, scientific founders and first-time CEOs to drive the successful development of their technologies to enable new treatment options for patients with serious disease.
Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The company`s leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a B-cell targeted antibody for acute lymphoblastic leukemia and an antibody for calcium channels expressed by the immune system. Pascal is headquartered in Vancouver, Canada. The company trades on the TSX Venture Exchange under the symbol “PAS”.
RootPath, Inc. is a Cambridge, MA-based early-stage biotechnology company focusing on next-generation immuno- and cell-therapy.
BioXcel is a Branford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Shenandoah Biotechnology is a Warminster, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.